🔗 Permalink

Assignee profile:

1GLOBE BIOMEDICAL CO., LTD.

City:

Beijing

Country:

China

Published Applications:

Last publication date:

2025-07-24

Patent Grants:

Last grant date:

2025-06-03

Top Inventors for applications by 1GLOBE BIOMEDICAL CO., LTD.

These are the the leading inventors for applications assigned to 1GLOBE BIOMEDICAL CO., LTD.:

CHIANG J. LI 11 Cambridge, MA United States
SHYAM UNNIRAMAN 5 Newton, MA United States
Jifeng Liu 3 Winchester, MA United States
HANNAH BADER 2 Waltham, MA United States

Zoltan DERDAK 2 Attleboro, MA United States
Suzhen CHEN 1 Wellesley, MA United States
Darko STEVANOVIC 1 Jamaica Plain, MA United States
MITHILESH JHA 1 Sharon, MA United States

Alan Lau 1 Malden, MA United States

Recent patent applications by 1GLOBE BIOMEDICAL CO., LTD.

1GLOBE BIOMEDICAL CO., LTD. based in Beijing, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-24

US20250235425A1

Human necessities

New Combination Solution for Treating Chemotherapy Refractory Cancer

#2 | 2022-02-10 ✅ Patent 12,318,381 granted on 2025-06-03

US20220040172A1

Human necessities

Treatment for non-alcoholic fatty liver disease

#3 | 2021-12-23 ✅ Patent 12,257,227 granted on 2025-03-25

US20210393571A1

Human necessities

Combination solution for treating chemotherapy refractory cancer

#4 | 2021-12-16 ✅ Patent 12,378,295 granted on 2025-08-05

US20210388049A1

Chemistry; metallurgy

Novel Rationally Designed Protein Compositions

#5 | 2021-10-28 ✅ Patent 12,391,758 granted on 2025-08-19

US20210332138A1

Chemistry; metallurgy

NOVEL CANCER IMMUNOTHERAPY ANTIBODY COMPOSITIONS

#6 | 2021-09-09 ✅ Patent 12,390,460 granted on 2025-08-19

US20210275523A1

Human necessities

TREATMENT FOR OBESITY

#7 | 2020-09-10 ✅ Patent 11,370,748 granted on 2022-06-28

US20200283378A1

Chemistry; metallurgy

Therapeutics for central nervous system disorders

#8 | 2020-08-13 ✅ Patent 11,667,693 granted on 2023-06-06

US20200255493A1

Chemistry; metallurgy

Synthetic biology-based ADCC technology

#9 | 2017-12-21 ✅ Patent 12,247,062 granted on 2025-03-11

US20170362299A1

Chemistry; metallurgy

Soluble universal ADCC-enhancing synthetic fusion gene and peptide technology and its use thereof

#10 | 2016-12-08 ✅ Patent 10,526,392 granted on 2020-01-07

US20160355566A1

Chemistry; metallurgy

Synthetic biology-based ADCC technology

#11 | 2013-12-12 ✅ Patent 9,481,884 granted on 2016-11-01

US20130330824A1

Chemistry; metallurgy

Enabling the use of long dsRNA for gene targeting in mammalian and other selected animal cells

Also check out 1GLOBE BIOMEDICAL CO., LTD.'s (Beijing, China) applicant profile with 11 patent applications submitted.

AssigneeID:

381477 ⎘